Preliminary testing of this compound in a live nude mouse model under isoflurane anesthesia using a two-dimensional fluorescent optical imaging showed suitable localization in induced prostate cancer (PC3-PSCA-PSMA) tumor when delivered via intratumoral injection (IT) (Figure 6c, control Figure 6a). The gene discussed is FOLH1; the disease is prostate carcinoma.